NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

BACKGROUND: Triple Negative breast cancer (TNBC) is a poor outcome subgroup of breast cancer defined based on the absence of expression of ERα and PR and HER2 amplification. These hard to treat cancers lack targeted treatment options and are therefore treated with a standard of care (SoC) generic co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Mullan, Paul B., Bingham, Victoria, Haddock, Paula, Irwin, Gareth W., Kay, Elaine, McQuaid, Stephen, Buckley, Niamh E.
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6444590/
https://ncbi.nlm.nih.gov/pubmed/30935371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5407-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge